Literature DB >> 22886513

Atrial fibrillation ablation and heart failure.

Jonathan Man1, Francis E Marchlinski.   

Abstract

Atrial fibrillation (AF) worsens outcome in patients with systolic heart failure and the presence of heart failure (HF) predicts a 5- to 6-fold increase in risk of AF. In addition to loss of atrial systole, AF may contribute to left ventricular (LV) systolic dysfunction due a rapid ventricular rate, irregularity of rhythm and exacerbation of mitral regurgitation due to atrial dilatation. Elimination of atrial fibrillation with catheter ablation can improve ejection fraction and reduce heart failure symptoms and appears superior to AV node ablation and bi-ventricular pacing. AF ablation can restore sinus rhythm in most patients with heart failure. Additional study is warranted to identify which patients will receive maximum benefit from aggressive rhythm control and to determine efficacy in patients with diastolic heart failure.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22886513     DOI： 10.1007/s11886-012-0301-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  37 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry.

Authors:  Gaetano M De Ferrari; Catherine Klersy; Paolo Ferrero; Cecilia Fantoni; Diego Salerno-Uriarte; Lorenzo Manca; Paolo Devecchi; Giulio Molon; Miriam Revera; Antonio Curnis; Simona Sarzi Braga; Francesco Accardi; Jorge A Salerno-Uriarte
Journal:  Eur J Heart Fail       Date:  2006-12-14       Impact factor: 15.534

Review 3.  Hemodynamic effects of acute myocardial infarction in man.

Authors:  J Shillingford; M Thomas
Journal:  Prog Cardiovasc Dis       Date:  1967-05       Impact factor: 8.194

4.  Reversal of left ventricular dysfunction following ablation of atrial fibrillation.

Authors:  Philip J Gentlesk; William H Sauer; Edward P Gerstenfeld; David Lin; Sanjay Dixit; Erica Zado; David Callans; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2006-11-01

5.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

6.  Catheter ablation for atrial fibrillation in congestive heart failure.

Authors:  Li-Fern Hsu; Pierre Jaïs; Prashanthan Sanders; Stéphane Garrigue; Mélèze Hocini; Fréderic Sacher; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Christophe Scavée; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

7.  Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging.

Authors:  Boris A Lutomsky; Thomas Rostock; Andreas Koops; Daniel Steven; Kai Müllerleile; Helge Servatius; Imke Drewitz; Denis Ueberschär; Thorsten Plagemann; Rodolfo Ventura; Thomas Meinertz; Stephan Willems
Journal:  Europace       Date:  2008-04-01       Impact factor: 5.214

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

10.  Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.

Authors:  Tom De Potter; Antonio Berruezo; Lluis Mont; Maria Matiello; David Tamborero; Claudio Santibañez; Begoña Benito; Nibaldo Zamorano; Josep Brugada
Journal:  Europace       Date:  2010-01       Impact factor: 5.214
View more
  2 in total

Review 1.  Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians.

Authors:  Nebojša Mujović; Milan Marinković; Radoslaw Lenarczyk; Roland Tilz; Tatjana S Potpara
Journal:  Adv Ther       Date:  2017-07-21       Impact factor: 3.845

2.  Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway.

Authors:  Mingjiang Li; Xin Yi; Lele Ma; Yanli Zhou
Journal:  Exp Ther Med       Date:  2013-08-28       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.